|
Markt geschlossen -
Nasdaq
22:00:00 13.11.2026
|
Perf. 5 T | Veränd. 1. Jan. | ||
| 28.83 USD | +1.05% |
|
-3.48% | +6.15% |
| 05.11. | Celldex Therapeutics, Inc. veröffentlicht Geschäftsergebnisse für das dritte Quartal und die neun Monate bis zum 30. September 2026 | CI |
| 22.09. | Größte Verlierer zur Mittagszeit | MT |
Hauptkonkurrenten
| % | % 5 Tage | Veränd. 1 Monat | Veränd. 3 Monate | % 1. Jan. | Perf. 1 Jahr | Perf. 3 Jahre | Veränd. 5 Jahre | Veränd. 10 Jahre | Marktkap.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +1.05% | -3.48% | +3.57% | -31.28% | +6.15% | +12.84% | +3.33% | -31.31% | -60.93% | 2.26 Mrd. | |
| -2.69% | -0.48% | -5.11% | -8.13% | +61.41% | +53.97% | +70.99% | +13.50% | - | 66.33 Mrd. | |
| -0.92% | +7.67% | +17.72% | +20.30% | +22.54% | +12.64% | +92.55% | +224.85% | +6’178.77% | 60.62 Mrd. | |
| 0.00% | +0.39% | +13.77% | +18.38% | +23.84% | +22.34% | +90.83% | -9.63% | +276.70% | 55.5 Mrd. | |
| +0.14% | +2.35% | +18.51% | +19.87% | +37.11% | +13.86% | +106.64% | +10.00% | +1’088.42% | 47.58 Mrd. | |
| -2.21% | -2.47% | +1.19% | +12.03% | +17.62% | +20.18% | +32.24% | +4.10% | +244.80% | 43.69 Mrd. | |
| -2.30% | -10.40% | -10.97% | -15.42% | +116.31% | +154.30% | +725.54% | +424.79% | - | 37.27 Mrd. | |
| +2.15% | +1.42% | +19.02% | +6.47% | +24.14% | +14.58% | +54.23% | +21.92% | +193.10% | 36.57 Mrd. | |
| -2.32% | -2.24% | +38.98% | +70.10% | +70.10% | +76.50% | +54.55% | +22.18% | +186.86% | 32.22 Mrd. | |
| +2.62% | +5.90% | +23.90% | -2.09% | -30.38% | -37.29% | +393.72% | +280.29% | +701.85% | 26.58 Mrd. | |
| -4.38% | -1.85% | -6.03% | +3.54% | +48.66% | +40.28% | -2.22% | -55.49% | - | 24.45 Mrd. | |
| +0.66% | -2.18% | -3.45% | -8.05% | -10.08% | -16.97% | -14.96% | -64.05% | - | 21.22 Mrd. | |
| -0.44% | +0.13% | +6.05% | +13.04% | +16.43% | +10.82% | +131.76% | +194.74% | +1’785.10% | 18.29 Mrd. | |
| +3.12% | +7.23% | +21.32% | +10.82% | - | - | - | - | - | 18.06 Mrd. | |
| +1.10% | +8.66% | +15.97% | -8.00% | +225.70% | +218.59% | +393.11% | +1’472.94% | +873.51% | 17.38 Mrd. | |
| -1.20% | -0.82% | +13.13% | +34.66% | +57.43% | +65.67% | +222.88% | +281.22% | +311.69% | 16.84 Mrd. | |
| +0.02% | -0.74% | +13.00% | +24.90% | +40.99% | +49.22% | +69.00% | -16.98% | +119.95% | 16.58 Mrd. | |
| -0.83% | +0.13% | +11.91% | +20.68% | +69.43% | +101.40% | +89.48% | -12.42% | +350.27% | 16.19 Mrd. | |
| -2.92% | -4.93% | +15.20% | +19.31% | +6.82% | +20.02% | -27.08% | -31.83% | +140.81% | 14.58 Mrd. | |
| -2.18% | -1.50% | +2.47% | -13.93% | +14.23% | -3.66% | +417.92% | - | - | 13.65 Mrd. | |
| Durchschnitt | -0.58% | -0.34% | +10.51% | +9.36% | +43.08% | +43.65% | +152.87% | +151.60% | +885.06% | 29 Mrd. | |
| Nach Marktkapitalisierung gewichteter Durchschnitt | -0.79% | +0.02% | +10.33% | +11.28% | +42.70% | +41.11% | +147.27% | +125.60% | +1’350.47% |
- Börse
- Aktien
- A2PEAB Aktie
- Sektor Celldex Therapeutics, Inc.
Bitte wählen Sie Ihre Edition
Alle länderspezifischen Finanzinformationen
